Seelos Therapeutics
SEEL
#10517
Rank
โ‚ฌ0.18 M
Marketcap
0,32ย โ‚ฌ
Share price
-31.49%
Change (1 day)
-98.22%
Change (1 year)

Earnings for Seelos Therapeutics (SEEL)

Earnings in 2024 (TTM): โ‚ฌ4.2 Million

According to Seelos Therapeutics 's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -โ‚ฌ32.7 Million, an increase over its 2022 earnings that were of -โ‚ฌ63.58 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Seelos Therapeutics from 2000 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) โ‚ฌ4.2 M-112.87%
2023 -โ‚ฌ32.7 Million-48.58%
2022 -โ‚ฌ63.58 Million14.07%
2021 -โ‚ฌ55.73 Million240.34%
2020 -โ‚ฌ16.38 Million-62.76%
2019 -โ‚ฌ43.98 Million587.73%
2018 -โ‚ฌ6.4 Million-36.54%
2017 -โ‚ฌ10.08 Million74.83%
2016 -โ‚ฌ5.77 Million-63.26%
2015 -โ‚ฌ15.69 Million-18.06%
2014 -โ‚ฌ19.15 Million46.19%
2013 -โ‚ฌ13.1 Million-31.67%
2012 -โ‚ฌ19.17 Million
2010 -โ‚ฌ17.96 Million448.63%
2009 -โ‚ฌ3.28 Million-25.83%
2008 -โ‚ฌ4.42 Million-45.65%
2007 -โ‚ฌ8.12 Million2.82%
2006 -โ‚ฌ7.9 Million-41.86%
2005 -โ‚ฌ13.58 Million-9.27%
2004 -โ‚ฌ14.97 Million114.92%
2003 -โ‚ฌ6.97 Million-70.78%
2002 -โ‚ฌ23.84 Million60.2%
2001 -โ‚ฌ14.88 Million70.3%
2000 -โ‚ฌ8.74 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-โ‚ฌ0.13 Billion-3,626.04%๐Ÿ‡บ๐Ÿ‡ธ USA